Detalhe da pesquisa
1.
Risk of serious infections in arthritis patients treated with biological drugs: a matched cohort study and development of prediction model.
Rheumatology (Oxford)
; 60(8): 3834-3844, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493342
2.
Overall infection risk in rheumatoid arthritis during treatment with abatacept, rituximab and tocilizumab; an observational cohort study.
Rheumatology (Oxford)
; 59(8): 1949-1956, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31764977
3.
Comparative Effectiveness of Certolizumab Pegol, Abatacept, and Biosimilar Infliximab in Patients With Rheumatoid Arthritis Treated in Routine Care: Observational Data From the Danish DANBIO Registry Emulating a Randomized Trial.
Arthritis Rheumatol
; 71(12): 1997-2004, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31268624